Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China · Delayed Price · Currency is CNY 12.88
-0.32 (-2.42%)
Jun 2, 2026, 3:00 PM CST
Cabio Biotech (Wuhan) Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,119 | 3,883 | 3,203 | 3,013 | 5,438 | 7,373 | |
Market Cap Growth | -50.30% | 21.24% | 6.31% | -44.60% | -26.24% | 55.15% |
Enterprise Value | 1,947 | 3,741 | 3,077 | 2,760 | 4,910 | 6,676 |
Last Close Price | 12.88 | 23.28 | 18.88 | 17.49 | 31.30 | 42.04 |
PE Ratio | 39.08 | 27.02 | 25.79 | 32.97 | 84.48 | 57.34 |
Forward PE | - | 19.04 | 22.89 | 23.21 | - | - |
PS Ratio | 5.07 | 6.90 | 5.77 | 6.79 | 12.55 | 21.00 |
PB Ratio | 1.33 | 2.36 | 2.04 | 2.02 | 3.82 | 5.34 |
P/TBV Ratio | 1.37 | 2.44 | 2.12 | 2.10 | 3.93 | 5.39 |
P/FCF Ratio | 21.82 | 30.93 | - | - | - | - |
P/OCF Ratio | 9.44 | 14.38 | 18.51 | 43.73 | 30.83 | 71.38 |
PEG Ratio | - | 0.75 | 0.75 | 0.75 | - | - |
EV/Sales Ratio | 4.66 | 6.64 | 5.54 | 6.22 | 11.33 | 19.02 |
EV/EBITDA Ratio | 18.92 | 19.74 | 20.05 | 22.42 | 54.31 | 53.40 |
EV/EBIT Ratio | 47.28 | 28.88 | 31.43 | 36.28 | 76.29 | 65.65 |
EV/FCF Ratio | 20.04 | 29.80 | - | - | - | - |
Debt / Equity Ratio | 0.13 | 0.05 | 0.01 | 0.01 | 0.02 | 0.00 |
Debt / EBITDA Ratio | 2.01 | 0.45 | 0.12 | 0.10 | 0.36 | 0.02 |
Debt / FCF Ratio | 2.13 | 0.69 | - | - | - | - |
Net Debt / Equity Ratio | -0.11 | -0.12 | -0.08 | -0.15 | -0.35 | -0.49 |
Net Debt / EBITDA Ratio | -1.76 | -1.01 | -0.87 | -1.84 | -5.47 | -5.39 |
Net Debt / FCF Ratio | -1.85 | -1.53 | 3.47 | 0.99 | 6.76 | 9.60 |
Asset Turnover | 0.23 | 0.32 | 0.34 | 0.28 | 0.28 | 0.25 |
Inventory Turnover | 1.46 | 2.00 | 2.64 | 2.73 | 3.29 | 2.46 |
Quick Ratio | 2.57 | 3.18 | 4.67 | 4.77 | 4.35 | 14.93 |
Current Ratio | 3.76 | 4.44 | 6.45 | 6.31 | 5.03 | 16.59 |
Return on Equity (ROE) | 3.11% | 8.67% | 7.84% | 5.92% | 4.39% | 9.71% |
Return on Assets (ROA) | 1.41% | 4.57% | 3.71% | 2.95% | 2.63% | 4.49% |
Return on Invested Capital (ROIC) | 2.19% | 7.70% | 6.22% | 5.98% | 6.19% | 14.97% |
Return on Capital Employed (ROCE) | 2.40% | 7.60% | 6.20% | 5.10% | 4.50% | 7.30% |
Earnings Yield | 2.60% | 3.70% | 3.88% | 3.03% | 1.18% | 1.74% |
FCF Yield | 4.58% | 3.23% | -1.20% | -7.59% | -1.34% | -0.95% |
Dividend Yield | 1.56% | - | 1.06% | 1.14% | 0.69% | 0.56% |
Payout Ratio | 66.24% | 24.95% | 27.38% | 40.04% | 61.90% | 31.01% |
Buyback Yield / Dilution | -0.75% | 0.44% | 0.80% | 0.11% | -0.69% | -0.31% |
Total Shareholder Return | 0.81% | 0.44% | 1.87% | 1.26% | -0.01% | 0.26% |